EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance

Alexandre Bentaberry-Rosa iD, Yvan Nicaise, Caroline Delmas iD, Valérie Gouazé-Andersson iD, Elizabeth Cohen-Jonathan-Moyal, Catherine Seva

Cancers · 20.12.2023 · 16 (1) · 27

DOI: 10.3390/cancers16010027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 20.12.2023. Verfasst von Alexandre Bentaberry-Rosa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Cancérologie de Toulouse (CRCT), INSERM U1037, Université Toulouse III Paul Sabatier, ERL5294 CNRS, 31062 Toulouse, France. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm, La Ligue Contre le Cancer, Association de Recherche sur les Tumeurs Cérébrales (ARTC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GSCs play an important role in GBM recurrence. Understanding the resistance mechanisms in these cells is therefore crucial for radiation therapy optimization. In this study, using patient-derived GSCs, we demonstrate that GDF15, a cytokine belonging to the TGF-β superfamily, is regulated by irradiation (IR) and the transcription factor WWTR1/TAZ. Blocking WWTR1/TAZ using specific siRNAs significantly reduces GDF15 basal expression and reverses the upregulation of this cytokine induced by IR. Furthermore, we demonstrate that GDF15 plays an important role in GSC radioresistance. Targeting GDF15 expression by siRNA in GSCs expressing high levels of GDF15 sensitizes the cells to IR. In addition, we also found that GDF15 expression is critical for GSC spheroid formation, as GDF15 knockdown significantly reduces the number of GSC neurospheres. This study suggests that GDF15 targeting in combination with radiotherapy may be a feasible approach in patients with GBM.

Schlagwörter

Stichwörter der Autor:innen

GDF15cancer stem cellsglioblastomasradioresistancesignaling

Autor:innen und Institutionen

  • Centre de Recherche en Cancérologie de Toulouse (CRCT), INSERM U1037, Université Toulouse III Paul Sabatier, ERL5294 CNRS, 31062 Toulouse, France.
  • IUCT-Oncopole, 31100 Toulouse, France.

ORCID-Profile: Alexandre Bentaberry-Rosa, Caroline Delmas, Valérie Gouazé-Andersson

Förderung

  • Inserm
  • La Ligue Contre le Cancer
  • Association de Recherche sur les Tumeurs Cérébrales (ARTC)
  • Ligue Nationale contre le Cancer

Zitieren

APA

Bentaberry-Rosa, A., Nicaise, Y., Delmas, C., Gouazé-Andersson, V., Cohen-Jonathan-Moyal, E., & Seva, C. (2023). Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance. Cancers, 16(1), 27. https://doi.org/10.3390/cancers16010027

Vancouver

Bentaberry-Rosa A, Nicaise Y, Delmas C, Gouazé-Andersson V, Cohen-Jonathan-Moyal E, Seva C. Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance. Cancers. 2023;16(1):27. doi:10.3390/cancers16010027

BibTeX
@article{BentaberryRosa2023,
  author = {Bentaberry-Rosa, Alexandre and Nicaise, Yvan and Delmas, Caroline and Gouazé-Andersson, Valérie and Cohen-Jonathan-Moyal, Elizabeth and Seva, Catherine},
  title = {Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance},
  journal = {Cancers},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {27},
  doi = {10.3390/cancers16010027}
}
Kostenlos starten →